Keywords: Prostate cancer recurrence; Androgen deprivation therapy (ADT); Choline-PET/CT; PSMA-PET/CT; Robotic salvage lymph node dissection; Complete biochemical response (cBCR); ADT; androgen deprivation therapy; BCR; biochemical recurrence; cBCR; complete bioche
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: prostatic neoplasms; biomarkers; tumor; neoplastic cells; circulating; bone marrow; neoplasm metastasis; 4P; PSA, PAP, PSCA and PSMA cocktail; AR; androgen receptor; BM; bone marrow; CK; pan-cytokeratin; CTC; circulating tumor cell; DTC; disseminated tumo
Keywords: IGZO; Indium gallium ZnO; CMOS; Complementary metal-oxide semiconductor; PAC; Polymer-like amorphous carbon; AFP; Anti-α-feptoprotein; PSA; Prostate specific antigen; cTnT; Cardiac troponin T; CEA; Carcinoembryonic antigen; PNA; Peptide nucleic acid; APT
Keywords: PANI; Polyaniline; As; Arsenic; Hg; Mercury; Cr; Chromium; Pb; Lead; Ni; Nickel; Cd; Cadmium; Co; Cobalt; Cu; Copper; RHS; Rice husk; WS; Walnut shell; OP; Orange peel; SFSS; Sunflower seed shells; ES; Eggshell; SD; Sawdust; PP; Pomegranate peel; CP; Carr
Keywords: PSMA; Brush border enzyme-cleavable linker; Kidney uptake; Radioiodine; Astatine-211;
Keywords: MDR; multi-drug resistance; PPI; polypropyleneimine; RBC; red blood cell; WBC; white blood cell; LDH; lactate dehydrogenase; EPR; enhances permeability and retention; FA; folic acid; FR; FA receptor; SMUT; sodium-dependent multi-vitamin transporter; FITC;
Keywords: 56MESS; (1S2S-diaminocyclohexane)platinum(II)] dichloride; AIBN; 2,2â²-azobisisobutyronitrile; Apt; aptamer; AUC; area under curve; BBR3464; (trans,trans,trans)-bis-mu-(hexane-16-diamine)-mu-[diammineplatinum(II)]bis[diammine(chloro)platinum(II)] tetrani
Keywords: Ag@MSN; silver hybridized mesoporous silica nanoparticles; AFP; alpha-fetoprotein; APBA; 3-aminophenylboroic acid; APTES; 3-aminopropyltriethoxysilane; APTMS; aldehyde propyltrimethoxysilane; AuNPs@GMCs; graphitized mesoporous carbon-gold nanoparticles; B
Metal complexes of tridentate tripod ligands in medical imaging and therapy
Keywords: 2-TicNMe; tris(N-methylimidazol-2-yl)carbonil; 2-TipiPr2; tris(1,4-diisopropylimidazol-2-yl)phosphane; 4-TipH; tris(imidazole-4-yl)phosphane; AO; acridine orange; BBB; blood brain barrier; BBN; bombesin; bdmpza; 3,3-bis(3,5-dimethylpyrazol-1-yl)acetate; b
Keywords: Biomarkers; Sipuleucel-T; Ipilimumab; Nivolumab; Ki-67; MDSCs; Tregs; ELISpot; Renal cell; Prostate cancer; Bladder cancer; CTCs; PSA; PSMA; IL-2; Immunoscore; Cytokines
Keywords: Prostate cancer; CT; MRI; Bone scintigraphy; PET; Choline; PSMA;
Keywords: TR; trypsin; CT; α-chymotrypsin; GA; glutaraldehyde; THF; tetrahydrofuran; BAPNA; Nα-benzoyl-l-arginine 4-nitroanilide; PS; polystyrene; PSMA; poly(styrene-co-maleic anhydride); NPs; magnetic nanoparticles; NFs; nanofibers; NP-NFs; magnetic nanoparticle
Keywords: CCD; charge-coupled-device; IF; intensity Factor; PCA; principal component analysis; ANN; artificial neural network; PVP; poly(n-vinyl pyrrolidone); PSA; poly(styrene-co-allyl alcohol); PVB; poly(vinyl butyl); PSMA; poly(styrene-co-maleic anhydride); PS;
Keywords: 18F-FAZA; 18F-labeled fluoroazomycin arabinoside; 18F-FDG; 18F-labeled fluorodeoxyglucose; 18F-FLT; 18F-labeled fluorothymidine; 18F-HX4; 18F-labeled flortanidazole; 18F-MISO; 18F-labeled fluoromisonidazole; 62Cu-ATSM; 62Cu-labeled diacetyl-bis(N-methylth
Keywords: BCS; biopharmaceutics classification system; bFGF; basic fibroblast growth factor; BMC; bone morphogenetic protein; CA; cellulose acetate; CD; cyclodextrin; CS; chitosan; CS-EDTA; chitosan-ethylenediaminetetraacetic acid; CR; controlled release; DMAc;
Keywords: Prostate cancer; Tumor microenvironment; PSMA; PSA; PSCA; HER2;
Diagnosing small bowel carcinoid tumor in a patient with oligometastatic prostate cancer imaged with PSMA-Targeted [18F]DCFPyL PET/CT: Value of the PSMA-RADS-3D Designation
Keywords: Prostate cancer; PSMA; Carcinoid;
Efficacy Against Human Prostate Cancer by Prostate-specific Membrane Antigen-specific, Transforming Growth Factor-β Insensitive Genetically Targeted CD8+ T-cells Derived from Patients with Metastatic Castrate-resistant Disease
Keywords: PSMA; TGF-β; CD8+ T-cells; Prostate cancer; mCRPC;
Incidental Detection of Basaloid Thymic Carcinoma With 68Ga-PSMA-11 PET/CT in a Patient With Recurrent Prostate Cancer
Keywords: Biochemical recurrence; Incidental finding; Positron emission tomography; Prostate cancer; PSMA;
Fluorine-18 Prostate-specific Membrane Antigen-1007 Positron Emission Tomography/Computed Tomography and Multiparametric Magnetic Resonance Imaging in Diagnostics of Local Recurrence in a Prostate Cancer Patient After Recent Radical Prostatectomy
Keywords: [18F]PSMA-1007; mpMRI; PET/CT; Prostate cancer; PSMA;
Development of a Ga-68 labeled PET tracer with short linker for prostate-specific membrane antigen (PSMA) targeting
Keywords: PSMA; NOTA-GUL; DOTA-GUL; Gallium; Imaging probe; PET;
68Ga-PSMA PET/CT Replacing Bone Scan in the Initial Staging of Skeletal Metastasis in Prostate Cancer: A Fait Accompli?
Keywords: Bone scintigraphy; Molecular imaging; Prostate cancer; PSMA;
68Ga-PSMA Positron Emission Tomography/Computerized Tomography for Primary Diagnosis of Prostate Cancer in Men with Contraindications to or Negative Multiparametric Magnetic Resonance Imaging: A Prospective Observational Study
Keywords: prostatic neoplasms; positron emission tomography computed tomography; glutamate carboxypeptidase II; human; biopsy; diagnostic imaging; BPH; benign prostatic hyperplasia; CT; computerized tomography; 68Ga-PSMA; 68gallium labeled PSMA; GS; Gleason score;
Automated radiosynthesis of Al[18F]PSMA-11 for large scale routine use
Keywords: PSMA; Prostate cancer; Automation; AlF2+; Chelation;
Prostate Specific Membrane Antigen Targeted 18F-DCFPyL Positron Emission Tomography/Computerized Tomography for the Preoperative Staging of High Risk Prostate Cancer: Results of a Prospective, Phase II, Single Center Study
Keywords: prostatic neoplasms; 2-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid; positron-emission tomography; tomography; X-ray computed; diagnosis; CT; X-ray computerized tomography; MRI; magnetic response imaging; PCa; prosta
Targeting of folate-conjugated liposomes with co-entrapped drugs to prostate cancer cells via prostate-specific membrane antigen (PSMA)
Keywords: PSMA; Mitomycin-C; Prodrug; Doxorubicin; Liposomes; Folate receptor; Targeting; Prostate cancer;
Antibody-drug conjugates (ADCs): Potent biopharmaceuticals to target solid and hematological cancers- an overview
Keywords: Antibody-drug conjugates; Monoclonal antibodies; Anticancer; Drug resistance; Solid tumors; Hematological tumors; ADC; Antibody-Drug Conjugate; ALCL; Anaplastic Large Cell Lymphoma; ALL; Acute Lymphoblastic Leukemia; AML; Acute Myeloid Leukemia; BCMA; B C
OncologyTargeted Prostate Biopsy Using 68Gallium PSMA-PET/CT for Image Guidance
Keywords: Prostate cancer; PSMA; mpMRI; Targeted biopsy; mpMRI; multiparametric MRI; PSMA; prostate specific membrane antigen; 68Ga; 68Gallium; ROI; region of interest; CaP; prostate cancer;
Uptake of Prostate-Specific Membrane Antigen (PSMA) in adenoid cystic carcinoma - Is PSMA-PET-CT a helpful tool in radiation oncology?
Keywords: ACC; Adenoid cystic carcinoma; CTCAE; Common terminology criteria of adverse events; IMRT; intensity modulated radiotherapy; HIT; Heidelberg Ion Beam Therapy Center; IHC; Immunohistochemistry; PET-CT; Positron emission tomography-computed tomography; PSMA
68Gallium-Prostate-Specific Membrane Antigen PET/Computed Tomography for Primary and Secondary Staging in Prostate Cancer
Keywords: Prostate cancer staging; PSMA; PET/CT; Biochemical recurrence;
Validation of a [Al18F]PSMA-11 preparation for clinical applications
Keywords: PSMA; Prostate cancer; [Al18F]PSMA-11; PET imaging;
Assessment of PSMA targeting ligands bearing novel chelates with application to theranostics: Stability and complexation kinetics of 68Ga3Â +, 111In3Â +, 177Lu3Â + and 225Ac3Â +
Keywords: Targeted radiotherapy; PET; Bifunctional chelate; PSMA; Prostate cancer; 3p-C-DEPA;
Molecular Imaging in the Evaluation of 6 Doses of Ra-223 in High-Grade Prostate Cancer: Case Report
Keywords: High-grade prostate cancer; NaF; PET/CT; PSMA; Radium-223;
Microfluidic-integrated patterned ITO immunosensor for rapid detection of prostate-specific membrane antigen biomarker in prostate cancer
Keywords: ITO three-electrode patterning; Microfluidic; Electrostatic; Immunocomplex; PSMA; Prostate cancer;
PSMA ligands in prostate cancer - Probe optimization and theranostic applications
Keywords: PSMA; Prostate cancer; Imaging; Theranostics;
Development of CAR T cells designed to improve antitumor efficacy and safety
Keywords: 28z; CD28 + CD3ζ; 4-1BBL; 4-1BB ligand; B-ALL; B cell acute lymphatic leukemia; BBz; 4-1BB + CD3ζ; CAR; chimeric antigen receptor; CD40L; CD40 ligand; CRS; cytokine release syndrome; CTLA-4; cytotoxic T-lymphocyte associated protein 4; DCs; dendriti
PSMA-Based Detection of Prostate Cancer Bone Lesions With 18F-DCFPyL PET/CT: A Sensitive Alternative to 99mTc-MDP Bone Scan and Na18F PET/CT?
Keywords: Bone metastases; DCFPyL; PET/CT; Prostate cancer; PSMA;
68Ga-PSMA Positron Emission Tomography/Computed Tomography Provides Accurate Staging of Lymph Node Regions Prior to Lymph Node Dissection in Patients with Prostate Cancer
Keywords: Prostate cancer; PSMA; PET/CT; Positron emission tomography; Lymph node dissection;
Phase 1/2 multiple ascending dose trial of the prostate-specific membrane antigen-targeted antibody drug conjugate MLN2704 in metastatic castration-resistant prostate cancer
Keywords: Castration-resistant prostate cancer; DM1; Maytansinoid; MLN2704; Multiple ascending dose; PSMA;
Research articleCytokine profiling identifies an interaction of IL-6 and IL-1α to drive PSMA-PSA prostate clones
Keywords: PSMA; prostate specific membrane antigen; PSA; prostate specific antigen; BPH; benign prostate hyperplasia; PC; prostate cancer; IL-6; interleukin-6; IL-1α; interleukin-1α; TNF-α; tumor necrosis factor; PSMA; PSA; Benign prostate hyperplasia; Prostate
Discovery of PSMA-specific peptide ligands for targeted drug delivery
Keywords: Prostate cancer; PSMA; Peptide ligand; Phage display; Combinatorial biopanning
PSMA-specific theranostic nanoplex for combination of TRAIL gene and 5-FC prodrug therapy of prostate cancer
Keywords: Prostate cancer; Theranostic imaging; TRAIL; Gene therapy; Prodrug enzyme therapy; PSMA;
Folate-targeted amphiphilic cyclodextrin.siRNA nanoparticles for prostate cancer therapy exhibit PSMA mediated uptake, therapeutic gene silencing in vitro and prolonged circulation in vivo
Keywords: RNAi; Gene therapy; PSMA; Prostate cancer;
Original ArticleEnhanced growth inhibition of prostate cancer in vitro and in vivo by a recombinant adenovirus-mediated dual-aptamer modified drug delivery system
Keywords: Dual aptamer; Recombinant adenovirus; Doxorubicin; Targeted drug delivery system; Antitumor activity and toxicity; ADDP-Ad5; A10-3.2(DOX)/DUP-1-PEG-Ad5; PTEN; phosphatase and tensin homolog; DOX; doxorubicin; PEG; polyethylene glycol; PSMA; prostate-speci
PET/MRI:
Keywords: PET/MRI; PET/MR; Oncology; mMR; Whole-body imaging; AC; attenuation correction; CHO; [11C]choline; CMS; Centers for Medicare & Medicaid Services; CT; computed tomography; DWI; diffusion-weighted imaging; FACBC; anti-1-amino-3[18F]fluorocyclobutyl-1-carbox
Long non-coding RNA: A newly deciphered “code” in prostate cancer
Keywords: Androgen receptor; LNCaP; Biomarker; PCa; prostate cancer; ncRNA; non-coding RNAs; lncRNA; long ncRNA; miRNA; microRNA; snRNA; small nuclear RNA; siRNA; small interfering RNA; tRNA; transfer RNA; rRNA; ribosomal RNA; PCA3; PCa antigen 3; PIN; prostatic in
Design, synthesis and biological evaluation of PSMA/hepsin-targeted heterobivalent ligands
Keywords: PSMA; Hepsin; Prostate cancer; Heterobivalent ligands; Molecular imaging;
Ga68 labelled PSMA scans: Making sense of recurrent prostate cancer
Keywords: PSMA; FDG; GA68; Prostate;
A high-affinity [18 F]-labeled phosphoramidate peptidomimetic PSMA-targeted inhibitor for PET imaging of prostate cancer
Keywords: Flourine-18; PET; PSMA; Phosphoramidate
Bioconjugates for targeted delivery of therapeutic oligonucleotides
Keywords: ASO; antisense oligonucleotide; CDM; carboxylated dimethyl maleic acid; CPP; cell penetrating peptide; DPC; dynamic polyconjugate; ED50; median effective dose; GalNAc; N-acetylgalactosamine; LNP; lipid nanoparticle; NP; nanoparticle; ON; oligonucleotide;